Advertisement
Review Article| Volume 41, ISSUE 1, P51-67, March 2021

Pediatric Hemovigilance and Adverse Transfusion Reactions

Published:December 22, 2020DOI:https://doi.org/10.1016/j.cll.2020.10.004

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Morley S.L.
        • Hudson C.L.
        • Llewelyn C.A.
        • et al.
        Transfusion in children: epidemiology and 10-year survival of transfusion recipients.
        Transfus Med. 2016; 26: 111-117
        • Sapiano M.R.P.
        • Jones J.M.
        • Savinkina A.A.
        • et al.
        Supplemental findings of the 2017 National blood collection and utilization survey.
        Transfusion. 2020; 60: S17-S37
        • Lavoie J.
        Blood transfusion risks and alternative strategies in pediatric patients.
        Paediatr Anaesth. 2011; 21: 14-24
        • Vossoughi S.
        • Perez G.
        • Whitaker B.I.
        • et al.
        Analysis of pediatric adverse reactions to transfusions.
        Transfusion. 2018; 58: 60-69
        • Oakley F.D.
        • Woods M.
        • Arnold S.
        • et al.
        Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products.
        Transfusion. 2015; 55: 563-570
        • Gauvin F.
        • Lacroix J.
        • Robillard P.
        • et al.
        Acute transfusion reactions in the pediatric intensive care unit.
        Transfusion. 2006; 46: 1899-1908
        • Jones J.M.
        • Sapiano M.R.P.
        • Savinkina A.A.
        • et al.
        Slowing decline in blood collection and transfusion in the United States - 2017.
        Transfusion. 2020; 60: S1-S9
      1. International Haemovigilance Network. Available at: www.ihn-org.com. Accessed February 15, 2020.

        • Wood E.M.
        • Ang A.L.
        • Bisht A.
        • et al.
        International haemovigilance: what have we learned and what do we need to do next?.
        Transfus Med. 2019; 29: 221-230
        • Bolton-Maggs P.H.B.
        Conference report: international haemovigilance seminar and the SHOT annual symposium, 10-12 july 2018.
        Transfus Med. 2019; 29: 247-252
        • Chung K.W.
        • Harvey A.
        • Basavaraju S.V.
        • et al.
        How is national recipient hemovigilance conducted in the United States?.
        Transfusion. 2015; 55: 703-707
        • Hendrickson J.E.
        • Roubinian N.H.
        • Chowdhury D.
        • et al.
        Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication.
        Transfusion. 2016; 56: 2587-2596
      2. NHSN biovigilance component: hemovigilance Module surveillance protocol v2.5.2.
        (Available at:) (Accesssed February 15, 2020)
        • Savage W.J.
        • Hamilton R.G.
        • Tobian A.A.
        • et al.
        Defining risk factors and presentations of allergic reactions to platelet transfusion.
        J Allergy Clin Immunol. 2014; 133: 1772-1775.e9
        • Savage W.J.
        • Tobian A.A.
        • Savage J.H.
        • et al.
        Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets.
        Transfusion. 2015; 55: 296-300
        • Pedrosa A.K.
        • Pinto F.J.
        • Lins L.D.
        • et al.
        Blood transfusion reactions in children: associated factors.
        J Pediatr (Rio J). 2013; 89: 400-406
        • Yanagisawa R.
        • Tatsuzawa Y.
        • Ono T.
        • et al.
        Analysis of clinical presentations of allergic transfusion reactions and febrile non-haemolytic transfusion reactions in paediatric patients.
        Vox Sang. 2019; 114: 826-834
        • Li N.
        • Williams L.
        • Zhou Z.
        • et al.
        Incidence of acute transfusion reactions to platelets in hospitalized pediatric patients based on the US hemovigilance reporting system.
        Transfusion. 2014; 54: 1666-1672
        • Moncharmont P.
        • Meyer F.
        [Allergic adverse transfusion reactions in paediatrics, a 3-year study].
        Transfus Clin Biol. 2013; 20: 455-457
      3. S. Narayan (Ed), E. Poles, et al, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2018 Annual Report (2019). Available at: https://www.shotuk.org/wp-content/uploads/myimages/SHOTReport-2018_Web_Version.pdf. Accessed 15 February, 2020.

        • Ando J.
        • Masuda A.
        • Iizuka K.
        • et al.
        Congenital haptoglobin deficiency discovered on the occasion of anaphylaxis induced by platelet concentrate transfusion.
        Rinsho Ketsueki. 2016; 57: 2507-2511
        • Sandler S.G.
        • Eder A.F.
        • Goldman M.
        • et al.
        The entity of immunoglobulin A-related anaphylactic transfusion reactions is not evidence based.
        Transfusion. 2015; 55: 199-204
        • Thoren K.L.
        • Avecilla S.T.
        • Klimek V.
        • et al.
        A novel method for the laboratory workup of anaphylactic transfusion reactions in haptoglobin-deficient patients.
        Transfusion. 2020; 60: 682-687
        • Vossoughi S.
        • Parker-Jones S.
        • Schwartz J.
        • et al.
        Provider trends in paediatric and adult transfusion reaction reporting.
        Vox Sang. 2019; 114: 232-236
        • Duran J.
        • Siddique S.
        • Cleary M.
        Effects of leukoreduction and premedication with acetaminophen and diphenhydramine in minimizing febrile nonhemolytic transfusion reactions and allergic transfusion reactions during and after blood product administration: a literature review with recommendations for practice.
        J Pediatr Oncol Nurs. 2014; 31: 223-229
        • Sanders R.P.
        • Maddirala S.D.
        • Geiger T.L.
        • et al.
        Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children.
        Br J Haematol. 2005; 130: 781-787
        • Rujkijyanont P.
        • Monsereenusorn C.
        • Manoonphol P.
        • et al.
        Efficacy of oral acetaminophen and intravenous chlorpheniramine maleate versus placebo to prevent red cell transfusion reactions in children and adolescent with thalassemia: a prospective, randomized, double-blind controlled trial.
        Anemia. 2018; 2018: 9492303
        • van Hout F.M.A.
        • van der Meer P.F.
        • Wiersum-Osselton J.C.
        • et al.
        Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison.
        Transfusion. 2018; 58: 1021-1027
        • Pagano M.B.
        • Katchatag B.L.
        • Khoobyari S.
        • et al.
        Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy.
        Transfusion. 2019; 59: 1246-1251
        • Saadah N.H.
        • van der Bom J.G.
        • Wiersum-Osselton J.C.
        • et al.
        Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data.
        Br J Haematol. 2018; 180: 727-734
        • Karafin M.
        • Fuller A.K.
        • Savage W.J.
        • et al.
        The impact of apheresis platelet manipulation on corrected count increment.
        Transfusion. 2012; 52: 1221-1227
        • Malvik N.
        • Leon J.
        • Schlueter A.J.
        • et al.
        ABO-incompatible platelets are associated with increased transfusion reaction rates.
        Transfusion. 2020; 60: 285-293
        • Simons F.E.
        • Ebisawa M.
        • Sanchez-Borges M.
        • et al.
        2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.
        World Allergy Organ J. 2015; 8: 32
        • Cohen R.
        • Escorcia A.
        • Tasmin F.
        • et al.
        Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions.
        Transfusion. 2017; 57: 1674-1683
        • Kennedy L.D.
        • Case L.D.
        • Hurd D.D.
        • et al.
        A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions.
        Transfusion. 2008; 48: 2285-2291
        • Delaney M.
        • Wendel S.
        • Bercovitz R.S.
        • et al.
        Transfusion reactions: prevention, diagnosis, and treatment.
        Lancet. 2016; 388: 2825-2836
        • King K.E.
        • Shirey R.S.
        • Thoman S.K.
        • et al.
        Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.
        Transfusion. 2004; 44: 25-29
        • Semple J.W.
        • Rebetz J.
        • Kapur R.
        Transfusion-associated circulatory overload and transfusion-related acute lung injury.
        Blood. 2019; 133: 1840-1853
        • Lieberman L.
        • Petraszko T.
        • Yi Q.L.
        • et al.
        Transfusion-related lung injury in children: a case series and review of the literature.
        Transfusion. 2014; 54: 57-64
        • LaGrandeur R.G.
        • Tran M.
        • Merchant C.
        • et al.
        Transfusion-related acute lung injury following PDA ligation in a preterm neonate.
        J Neonatal Perinatal Med. 2017; 10: 339-342
        • Gupta S.
        • Som T.
        • Iyer L.
        • et al.
        Transfusion related acute lung injury in a neonate.
        Indian J Pediatr. 2012; 79: 1363-1365
        • Thalji L.
        • Thum D.
        • Weister T.J.
        • et al.
        Incidence and epidemiology of perioperative transfusion-related pulmonary complications in pediatric noncardiac surgical patients: a single-center, 5-year experience.
        Anesth Analg. 2018; 127: 1180-1188
        • De Cloedt L.
        • Emeriaud G.
        • Lefebvre E.
        • et al.
        Transfusion-associated circulatory overload in a pediatric intensive care unit: different incidences with different diagnostic criteria.
        Transfusion. 2018; 58: 1037-1044
        • Grev J.E.
        • Stanclova M.
        • Ellsworth M.A.
        • et al.
        Does red blood cell transfusion-related acute lung injury occur in premature infants? A retrospective cohort analysis.
        Am J Perinatol. 2017; 34: 14-18
        • Kalra A.
        • Palaniswamy C.
        • Patel R.
        • et al.
        Acute hypotensive transfusion reaction with concomitant use of angiotensin-converting enzyme inhibitors: a case report and review of the literature.
        Am J Ther. 2012; 19: e90-e94
        • Doria C.
        • Elia E.S.
        • Kang Y.
        • et al.
        Acute hypotensive transfusion reaction during liver transplantation in a patient on angiotensin converting enzyme inhibitors from low aminopeptidase P activity.
        Liver Transpl. 2008; 14: 684-687
        • Hui Y.
        • Wu Y.
        • Tormey C.A.
        The development of a novel molecular assay examining the role of aminopeptidase P polymorphisms in acute hypotensive transfusion reactions.
        Arch Pathol Lab Med. 2013; 137: 96-99
        • Du Pont-Thibodeau G.
        • Robitaille N.
        • Gauvin F.
        • et al.
        Incidence of hypotension and acute hypotensive transfusion reactions following platelet concentrate transfusions.
        Vox Sang. 2016; 110: 150-158
        • Fabron Jr., A.
        • Moreira Jr., G.
        • Bordin J.O.
        Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia.
        Sao Paulo Med J. 1999; 117: 38-39
        • Harris S.B.
        • Josephson C.D.
        • Kost C.B.
        • et al.
        Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A.
        Transfusion. 2007; 47: 1412-1417
        • Cooling L.
        ABO and platelet transfusion therapy.
        Immunohematology. 2007; 23: 20-33
        • Josephson C.D.
        • Castillejo M.I.
        • Grima K.
        • et al.
        ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
        Transfus Apher Sci. 2010; 42: 83-88
        • Balbuena-Merle R.
        • West F.B.
        • Tormey C.A.
        • et al.
        Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.
        Transfusion. 2019; 59: 1911-1915
        • Dunbar N.M.
        • Katus M.C.
        • Freeman C.M.
        • et al.
        Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
        Transfusion. 2015; 55: 1882-1888
        • Fontaine M.J.
        • Webster J.
        • Gomez S.
        • et al.
        How do I implement an automated screen for high-titer ABO antibody as an inventory management tool for ABO plasma-incompatible platelets?.
        Transfusion. 2015; 55: 2783-2789
        • Berseus O.
        • Boman K.
        • Nessen S.C.
        • et al.
        Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma.
        Transfusion. 2013; 53: 114S-123S
        • Heddle N.M.
        • Fung M.
        • Hervig T.
        • et al.
        Challenges and opportunities to prevent transfusion errors: a qualitative evaluation for safer transfusion (QUEST).
        Transfusion. 2012; 52: 1687-1695
        • Bolton-Maggs P.H.
        Transfusion and hemovigilance in pediatrics.
        Pediatr Clin North Am. 2013; 60: 1527-1540
        • Keir A.K.
        • New H.
        • Robitaille N.
        • et al.
        Approaches to understanding and interpreting the risks of red blood cell transfusion in neonates.
        Transfus Med. 2019; 29: 231-238
        • Goel R.
        • Tobian A.A.R.
        • Shaz B.H.
        Noninfectious transfusion-associated adverse events and their mitigation strategies.
        Blood. 2019; 133: 1831-1839
        • Refaai M.A.
        • Cahill C.
        • Masel D.
        • et al.
        Is it time to reconsider the concepts of "universal donor" and "ABO compatible" transfusions?.
        Anesth Analg. 2018; 126: 2135-2138
        • Tormey C.A.
        • Hendrickson J.E.
        Transfusion-related red blood cell alloantibodies: induction and consequences.
        Blood. 2019; 133: 1821-1830
        • Singhal D.
        • Kutyna M.M.
        • Chhetri R.
        • et al.
        Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.
        Haematologica. 2017; 102: 2021-2029
        • Karafin M.S.
        • Westlake M.
        • Hauser R.G.
        • et al.
        Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.
        Br J Haematol. 2018; 181: 672-681
        • Turkmen T.
        • Qiu D.
        • Cooper N.
        • et al.
        Red blood cell alloimmunization in neonates and children up to 3 years of age.
        Transfusion. 2017; 57: 2720-2726
        • Tyler L.N.
        • Harville T.O.
        • Backall D.P.
        Multiple alloantibodies after transfusion in an infant treated with Infliximab.
        N Engl J Med. 2007; 357: 2092-2093
        • Hata J.L.
        • Johnson M.S.
        • Booth G.S.
        Neonatal alloimmunization: a rare case of multiple alloantibody formation in a patient with disseminated histoplasmosis.
        Transfusion. 2013; 53: 1140-1141
        • Chou S.T.
        • Alsawas M.
        • Fasano R.M.
        • et al.
        American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.
        Blood Adv. 2020; 4: 327-355
        • Trompeter S.
        • Massey E.
        • Robinson S.
        Position paper on International Collaboration for Transfusion Medicine (ICTM) Guideline 'Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline'.
        Br J Haematol. 2020; 189: 424-427
        • Unni N.
        • Peddinghaus M.
        • Tormey C.A.
        • et al.
        Record fragmentation due to transfusion at multiple health care facilities: a risk factor for delayed hemolytic transfusion reactions.
        Transfusion. 2014; 54: 98-103
        • Nickel R.S.
        • Hendrickson J.E.
        • Yee M.M.
        • et al.
        Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
        Br J Haematol. 2015; 170: 247-256
        • Nickel R.S.
        • Horan J.T.
        • Fasano R.M.
        • et al.
        Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.
        Am J Hematol. 2015; 90: 1135-1141
        • McPherson M.E.
        • Anderson A.R.
        • Castillejo M.I.
        • et al.
        HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.
        Pediatr Blood Cancer. 2010; 54: 552-558
        • Nickel R.S.
        • Horan J.T.
        • Abraham A.
        • et al.
        Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
        Br J Haematol. 2020; 189: 162-170
        • Weinstock C.
        • Schnaidt M.
        Human leucocyte antigen Sensitisation and its impact on transfusion practice.
        Transfus Med Hemother. 2019; 46: 356-369
        • Siddon A.J.
        • Kenney B.C.
        • Hendrickson J.E.
        • et al.
        Delayed haemolytic and serologic transfusion reactions: pathophysiology, treatment and prevention.
        Curr Opin Hematol. 2018; 25: 459-467
        • Ness P.M.
        • Shirey R.S.
        • Thoman S.K.
        • et al.
        The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance.
        Transfusion. 1990; 30: 688-693
        • Tormey C.A.
        • Stack G.
        The persistence and evanescence of blood group alloantibodies in men.
        Transfusion. 2009; 49: 505-512
        • Hauser R.G.
        • Esserman D.
        • Karafin M.S.
        • et al.
        The evanescence and persistence of RBC alloantibodies in blood donors.
        Transfusion. 2020; 60: 831-839
        • Pirenne F.
        • Yazdanbakhsh K.
        How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.
        Blood. 2018; 131: 2773-2781
        • Gardner K.
        • Hoppe C.
        • Mijovic A.
        • et al.
        How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
        Br J Haematol. 2015; 170: 745-756
        • Mekontso Dessap A.
        • Pirenne F.
        • Razazi K.
        • et al.
        A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease.
        Am J Hematol. 2016; 91: 1181-1184
        • Narbey D.
        • Habibi A.
        • Chadebech P.
        • et al.
        Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.
        Am J Hematol. 2017; 92: 1340-1348
        • Nickel R.S.
        • Hendrickson J.E.
        • Fasano R.M.
        • et al.
        Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.
        Transfusion. 2016; 56: 107-114
        • Thein S.L.
        • Pirenne F.
        • Fasano R.M.
        • et al.
        Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal.
        Haematologica. 2020; 105: 539-544
        • Hauser R.G.
        • Hendrickson J.E.
        • Tormey C.A.
        TRIX with treats: the considerable safety benefits of a transfusion medicine registry.
        Transfusion. 2019; 59: 2489-2492
        • Delaney M.
        How I reduce the risk of missed irradiation transfusion events in children.
        Transfusion. 2018; 58: 2517-2521
        • Moncharmont P.
        Adverse transfusion reactions in transfused children.
        Transfus Clin Biol. 2019; 26: 329-335
        • Marschner S.
        • Fast L.D.
        • Baldwin 3rd, W.M.
        • et al.
        White blood cell inactivation after treatment with riboflavin and ultraviolet light.
        Transfusion. 2010; 50: 2489-2498
        • Busch M.P.
        • Bloch E.M.
        • Kleinman S.
        Prevention of transfusion-transmitted infections.
        Blood. 2019; 133: 1854-1864
        • Hong H.
        • Xiao W.
        • Lazarus H.M.
        • et al.
        Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance.
        Blood. 2016; 127: 496-502
        • Devine D.V.
        Implementation of pathogen inactivation technology: how to make the best decisions?.
        Transfusion. 2017; 57: 1109-1111
        • Bahar B.
        • Schulz W.L.
        • Gokhale A.
        • et al.
        Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen-reduced platelets.
        Br J Haematol. 2019; 188: 465-472
        • Schulz W.L.
        • McPadden J.
        • Gehrie E.A.
        • et al.
        Blood utilization and transfusion reactions in pediatric patients transfused with conventional or pathogen reduced platelets.
        J Pediatr. 2019; 209: 220-225
        • Hendrickson J.E.
        • Mendoza H.
        • Ross R.
        • et al.
        Investigation of increased platelet alloimmunization screening in the era of pathogen-reduced platelets treated with psoralen/UV light.
        Transfusion. 2020; 60: 650-651
        • US Dept of Health and Human Services
        Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion.
        Center for Biologics Evaluation and Research, 2019 (Available at:) (Accessed 15 February, 2020)
        • Glanternik J.R.
        • Baine I.L.
        • Rychalsky M.R.
        • et al.
        A cluster of cases of Babesia microti among neonates traced to a single unit of donor blood.
        Pediatr Infect Dis J. 2018; 37: 269-271
        • Coates T.D.
        Iron overload in transfusion-dependent patients.
        Hematol Am Soc Hematol Educ Program. 2019; 2019: 337-344
        • Kwiatkowski J.L.
        Current recommendations for chelation for transfusion-dependent thalassemia.
        Ann N Y Acad Sci. 2016; 1368: 107-114
        • Ruccione K.S.
        • Wood J.C.
        • Sposto R.
        • et al.
        Characterization of transfusion-derived iron deposition in childhood cancer survivors.
        Cancer Epidemiol Biomarkers Prev. 2014; 23: 1913-1919
        • Trovillion E.M.
        • Schubert L.
        • Dietz A.C.
        Iron overload in survivors of childhood cancer.
        J Pediatr Hematol Oncol. 2018; 40: 396-400
        • Ditzel Jr., R.M.
        • Anderson J.L.
        • Eisenhart W.J.
        • et al.
        A review of transfusion- and trauma-induced hypocalcemia. Is it time to change the lethal triad to the lethal diamond?.
        J Trauma Acute Care Surg. 2020; 88: 434-439
        • Lee A.C.
        • Reduque L.L.
        • Luban N.L.
        • et al.
        Transfusion-associated hyperkalemic cardiac arrest in pediatric patients receiving massive transfusion.
        Transfusion. 2014; 54: 244-254
        • Strauss R.G.
        RBC storage and avoiding hyperkalemia from transfusions to neonates & infants.
        Transfusion. 2010; 50: 1862-1865
        • Maheshwari A.
        • Patel R.M.
        • Christensen R.D.
        Anemia, red blood cell transfusions, and necrotizing enterocolitis.
        Semin Pediatr Surg. 2018; 27: 47-51
        • Patel R.M.
        • Knezevic A.
        • Shenvi N.
        • et al.
        Association of red blood cell transfusion, anemia, and necrotizing enterocolitis in very low-birth-weight infants.
        JAMA. 2016; 315: 889-897
        • Saroha V.
        • Josephson C.D.
        • Patel R.M.
        Epidemiology of necrotizing enterocolitis: New considerations regarding the influence of red blood cell transfusions and anemia.
        Clin Perinatol. 2019; 46: 101-117
        • MohanKumar K.
        • Namachivayam K.
        • Song T.
        • et al.
        A murine neonatal model of necrotizing enterocolitis caused by anemia and red blood cell transfusions.
        Nat Commun. 2019; 10: 3494
        • Curley A.
        • Stanworth S.J.
        • Willoughby K.
        • et al.
        Randomized trial of platelet-transfusion thresholds in neonates.
        N Engl J Med. 2019; 380: 242-251
        • Patel R.M.
        • Roback J.D.
        • Uppal K.
        • et al.
        Metabolomics profile comparisons of irradiated and nonirradiated stored donor red blood cells.
        Transfusion. 2015; 55: 544-552
        • Chen J.
        • Biller E.
        • Losos M.
        • et al.
        Irradiation and prolonged storage of red cells are associated with increased adverse events.
        Vox Sang. 2018; 113: 468-475
        • Fergusson D.A.
        • Hebert P.
        • Hogan D.L.
        • et al.
        Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial.
        JAMA. 2012; 308: 1443-1451
        • Spinella P.C.
        • Tucci M.
        • Fergusson D.A.
        • et al.
        Effect of fresh vs standard-issue red blood cell transfusions on multiple organ dysfunction syndrome in critically ill pediatric patients: a randomized clinical trial.
        JAMA. 2019; 322: 2179-2190
        • Savinkina A.A.
        • Haass K.A.
        • Sapiano M.R.P.
        • et al.
        Transfusion-associated adverse events and implementation of blood safety measures - findings from the 2017 National Blood Collection and Utilization Survey.
        Transfusion. 2020; 60: S10-S16